Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Freshpet
FRPT
$2.93B
| $520K | ﹤0.01% |
9,855
+2,101
| +27% | +$125K |
|
1702
e.l.f. Beauty
ELF
$4.89B
| $519K | ﹤0.01% |
9,387
| – | – |
|
1703
Navient
NAVI
$789M
| $517K | ﹤0.01% |
31,464
-31,464
| -50% | -$498K |
|
|
LIBY
1704
DELISTED
Liberty Resources Acquisition Corp. Class A Common Stock
LIBY
| $511K | ﹤0.01% |
50,000
-50,000
| -50% | -$507K |
|
1705
Kosmos Energy
KOS
$1.6B
| $510K | ﹤0.01% |
80,246
-80,246
| -50% | -$501K |
|
|
ARCH
1706
DELISTED
Arch Resources, Inc.
ARCH
| $509K | ﹤0.01% |
3,563
+453
| +15% | +$66.3K |
|
1707
Viavi Solutions
VIAV
$9.12B
| $508K | ﹤0.01% |
48,349
-29,753
| -38% | -$359K |
|
1708
Cohen & Steers
CNS
$4.23B
| $508K | ﹤0.01% |
7,861
+3,003
| +62% | +$188K |
|
1709
Varonis Systems
VRNS
$4.59B
| $507K | ﹤0.01% |
21,158
-21,158
| -50% | -$483K |
|
|
ENER
1710
DELISTED
Accretion Acquisition Corp
ENER
| $506K | ﹤0.01% |
50,000
-50,000
| -50% | -$500K |
|
|
RXDX
1711
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $504K | ﹤0.01% |
+4,586
| New | +$297K |
|
|
VCXB
1712
DELISTED
10X Capital Venture Acquisition Corp III
VCXB
| $504K | ﹤0.01% |
50,194
-50,194
| -50% | -$511K |
|
1713
Clearway Energy Class C
CWEN
$4.94B
| $502K | ﹤0.01% |
15,764
-15,766
| -50% | -$531K |
|
1714
Eastern Bankshares
EBC
$5.26B
| $502K | ﹤0.01% |
29,127
-29,129
| -50% | -$557K |
|
1715
TPG
TPG
$7.01B
| $502K | ﹤0.01% |
18,042
-46,512
| -72% | -$1.46M |
|
1716
Forward Air
FWRD
$444M
| $502K | ﹤0.01% |
4,782
| – | – |
|
1717
TruGolf
TRUG
$945K
| $501K | ﹤0.01% |
96
-96
| -50% | -$487K |
|
|
BECN
1718
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $500K | ﹤0.01% |
9,469
+1
| +0% | +$56 |
|
|
DALS
1719
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $500K | ﹤0.01% |
+50,000
| New | +$492K |
|
1720
Outfront Media
OUT
$5.61B
| $496K | ﹤0.01% |
30,432
-18,241
| -37% | -$308K |
|
1721
Dycom Industries
DY
$12B
| $495K | ﹤0.01% |
5,285
+1
| +0% | +$101 |
|
1722
Cogent Communications
CCOI
$676M
| $493K | ﹤0.01% |
8,634
| – | – |
|
|
BPMC
1723
DELISTED
Blueprint Medicines
BPMC
| $491K | ﹤0.01% |
11,210
-11,210
| -50% | -$538K |
|
1724
NorthWestern Energy
NWE
$4.23B
| $491K | ﹤0.01% |
8,268
| – | – |
|
1725
Evolent Health
EVH
$348M
| $489K | ﹤0.01% |
17,411
-9,813
| -36% | -$281K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.